Patent Applications published on Nov 13, 2025 - page 3

#601
US20250345222A1
Human necessities

SUPPORT ASSEMBLY ATTACHABLE TO A PATIENT SUPPORT AND PATIENT SUPPORT HAVING SAME

#602
US20250345223A1
Human necessities

Patient Transport Systems and Methods

#603
US20250345224A1
Human necessities

SUPPLY SYSTEM AND PROCESS FOR SUPPLYING A MEDICAL DEVICE WITH A FLUID, COMPRISING A WIRELESS ACTUATING UNIT

#604
US20250345225A1
Human necessities

Smart Dental Treatment Chair, and a System Utilizing Artificial Intelligence and Computerized Vision to Dynamically Monitor Real-Time Progress of an Ongoing Dental Treatment and to Provide Additional Benefits to Dental Patients

#605
US20250345226A1
Human necessities

Rehabilitation Apparatus

#606
US20250345227A1
Human necessities

UPPER BODY HUMAN TO MACHINE INTERFACE

#607
US20250345228A1
Human necessities

SPINAL SUPPORT DEVICES AND METHODS OF USE

#608
US20250345229A1
Human necessities

ISCHIAL BEARING CRUTCH

#609
US20250345230A1
Human necessities

PERSONAL MOBILITY SYSTEM

#610
US20250345231A1
Human necessities

Foot Massage Device

#611
US20250345232A1
Human necessities

INTELLIGENT MULTIFUNCTIONAL CUPPING DEVICE FOR TRADITIONAL CHINESE MEDICINE PHYSIOTHERAPY

#612
US20250345233A1
Human necessities

SYSTEMS AND METHODS FOR TREATING FLUID STASIS

#613
US20250345234A1
Human necessities

GAS-TYPE LYMPHATIC DRAINAGE DEVICE

#614
US20250345235A1
Human necessities

MASSAGE BALL AND MASSAGE DEVICE

#615
US20250345236A1
Human necessities

Motion Controlled Toy

#616
US20250345237A1
Human necessities

RESTRAINTS WITH SENSORS FOR MECHANICAL CPR DEVICE

#617
US20250345238A1
Human necessities

INFLATABLE MASSAGE POOL

#618
US20250345239A1
Human necessities

METHOD AND APPARATUS FOR DETERMINING ABDOMINAL ACUPUNCTURE POINTS, MOXIBUSTION ROBOT, AND STORAGE MEDIUM

#619
US20250345240A1
Human necessities

Rotary Pillbox

#620
US20250345241A1
Human necessities

ADAPTER FOR USE IN A PLANETARY MIXER

#621
US20250345242A1
Human necessities

VIAL ADAPTER AND FILL ROD FOR USER-WEARABLE INFUSION PUMP SYSTEM

#622
US20250345243A1
Human necessities

HANDS-FREE MEDICAL VIAL STABILIZATION DEVICE

#623
US20250345244A1
Human necessities

INTELLIGENT MEDICATION DISPENSING BOX

#624
US20250345245A1
Human necessities

SYSTEM FOR MANAGING DISPENSING OF MEDICATION

#625
US20250345246A1
Human necessities

INTRAORAL GASTROINTESTINAL ACCESS DEVICE AND RELATED METHODS

#626
US20250345247A1
Human necessities

DENTAL WORKPIECE AND METHOD FOR PRODUCING SAME

#627
US20250345248A1
Human necessities

HYPERBRANCHED POLYGLYCEROL-COATED PARTICLES AND METHODS OF MAKING AND USING THEREOF

#628
US20250345249A1
Human necessities

TOPICAL COMPOSITIONS

#629
US20250345250A1
Human necessities

SELF-EMULSIFIED EMULSION COSMETIC COMPOSITION

#630
US20250345251A1
Human necessities

IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS

#631
US20250345252A1
Human necessities

COMPOSITE MICROCAPSULES

#632
US20250345253A1
Human necessities

CLEANING POWDER AND WHITENING ORAL CARE FORMULATIONS

#633
US20250345254A1
Human necessities

FORMULATIONS AND USES OF RESVERATROL

#634
US20250345255A1
Human necessities

COMPOSITIONS FOR IMPROVING NAIL HEALTH

#635
US20250345256A1
Human necessities

EMULSION WITH GLYCERYL CAPRYLATE AND AT LEAST ONE PPG ALKYL ETHER

#636
US20250345257A1
Human necessities

USE OF SACCHARIDES FOR CRYOPROTECTION AND RELATED TECHNOLOGY

#637
US20250345258A1
Human necessities

COMPOSITION CONTAINING NIDOGEN FOR IMPROVING SKIN CONDITION, TREATING SKIN DAMAGE OR MAINTAINING STEM CELL FUNCTION

#638
US20250345259A1
Human necessities

SEAWEED-DERIVED COSMETIC COMPOSITIONS

#639
US20250345260A1
Human necessities

COSMETIC PRODUCT FOR TEMPORARILY SHAPING KERATIN-CONTAINING FIBERS

#640
US20250345261A1
Human necessities

FORMULATIONS FOR PREVENTING MOSQUITO BITES

#641
US20250345262A1
Human necessities

LOW-SUBSTITUTED CELLULOSE ETHER SPHERICAL MICROPARTICLE, AND COSMETIC COMPOSITION USING THE SAME, AS WELL AS METHOD OF PRODUCING LOW-SUBSTITUTED CELLULOSE SPHERICAL MICROPARTICLE

#642
US20250345263A1
Human necessities

PRODUCTION METHOD FOR AQUEOUS COMPOSITION

#643
US20250345264A1
Human necessities

FRUIT-DERIVED VESICLES AND COSMETIC COMPOSITION COMPRISING SAME

#644
US20250345265A1
Human necessities

ACTIVE PRINCIPLE COMPRISING A PARTICULAR EXTRACT OF PUNICA GRANATUM AND USES FOR PREVENTING AND/OR TREATING ACNE

#645
US20250345266A1
Human necessities

READY-TO-INFUSE OXYTOCIN COMPOSITIONS

#646
US20250345267A1
Human necessities

CHEWABLE PHARMACEUTICAL DOSAGE FORMS

#647
US20250345268A1
Human necessities

ORAL THIN FILM

#648
US20250345269A1
Human necessities

PACKAGING FOR RAPIDLY INFUSING COMPOSITION

#649
US20250345270A1
Human necessities

Liquid Oral Formulations of Netupitant and Palonosetron

#650
US20250345271A1
Human necessities

PRODUCT TO ENHANCE FERTILITY

#651
US20250345272A1
Human necessities

INJECTABLE AND 3D EXTRUSION PRINTABLE HYDROPHILIC SILICONE-BASED HYDROGEL FOR CONTROLLED DRUG RELEASE

#652
US20250345273A1
Human necessities

DEGRADABLE POLY(VINYL ALCOHOL) HYDROGELS FOR WOUND HEALING APPLICATIONS

#653
US20250345274A1
Human necessities

ALKALI METAL SALT COMBINATIONS OF INCOMPATIBLE ACTIVE PHARMACEUTICAL INGREDIENTS

#654
US20250345275A1
Human necessities

Micromolar Halogenated Fluorescein Assists in Full Skin-Thickness Wound Healing

#655
US20250345276A1
Human necessities

O/W-EMULSIONS COMPRISING SEMIFLUORINATED ALKANES

#656
US20250345277A1
Human necessities

Ionizable Liposome, Preparation Thereof, and Application Thereof in Gene Delivery

#657
US20250345278A1
Human necessities

Nanoparticles for Delivery of Nucleic Acid Cargos

#658
US20250345279A1
Human necessities

COVALENTLY CROSSLINKED POLYSACCHARIDES AND METHODS OF USE THEREOF

#659
US20250345280A1
Human necessities

Dry Powder Formulations for Messenger RNA

#660
US20250345281A1
Human necessities

METHODS FOR THE EXTRACTION OF DISPERSIBLE MICROCAPSULES (IMMUNOCONTRACEPTION)

#661
US20250345282A1
Human necessities

EXTRACELLULAR VESICLE COMPRISING ANTIGENIC PROTEIN OR GENE ENCODING SAME PROTEIN, AND USES THEREOF

#662
US20250345283A1
Human necessities

MACROPHAGE-DERIVED ENGINEERED VESICLES FOR TARGETED DELIVERY AND TREATMENT

#663
US20250345284A1
Human necessities

LIPID NANOPARTICLE (LNP) COMPOSITIONS AND METHODS OF USE THEREOF

#664
US20250345285A1
Human necessities

SONODYNAMIC THERAPY

#665
US20250345286A1
Human necessities

COMPOSITE LIPID NANOPARTICLE AND PREPARATION METHOD THEREOF, RNA VACCINE, DRUG AND USE

#666
US20250345287A1
Human necessities

COMPOSITION COMPRISING A MIXTURE OF AT LEAST ONE OIL AND ONE OR MORE SEMIFLUORINATED ALKANES, A USE OF THE COMPOSITION FOR TREATING A DISEASE AS WELL AS A METHOD OF PRODUCING THE COMPOSITION AND CORRESPONDING KITS

#667
US20250345288A1
Human necessities

Arterial Application of Low Dose Ethyl Alcohol Enables Blood-Brain Barrier (BBB) Transient Opening

#668
US20250345289A1
Human necessities

NANO-PARTICLES OF MENAQUINONE AND METHODS OF TREATMENT

#669
US20250345290A1
Human necessities

APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT AND RELATED PRODUCTS THEREOF

#670
US20250345291A1
Human necessities

METHOD OF TREATING POST-TRAUMATIC STRESS DISORDER

#671
US20250345292A1
Human necessities

COMBINATION OF ALBUTEROL AND BUDESONIDE FOR THE TREATMENT OF ASTHMA

#672
US20250345293A1
Human necessities

Plasminogen Activator Inhibitor-1 (PAI-1) Inhibitor and Method of Use

#673
US20250345294A1
Human necessities

BUPROPION AS A MODULATOR OF DRUG ACTIVITY

#674
US20250345295A1
Human necessities

LMK235 COMPOSITIONS AND METHODS

#675
US20250345296A1
Human necessities

COMPOSITIONS AND METHODS FOR THE MODULATION OF MITOPHAGY FOR USE IN TREATMENT OF MITOCHONDRIAL DISEASE

#676
US20250345297A1
Human necessities

ANTI-ARRHYTHMIC COMPOSITIONS AND METHODS

#677
US20250345298A1
Human necessities

APOE4 CORRECTORS AND METHODS OF USE

#678
US20250345299A1
Human necessities

COMBINATION AND COMPOSITION COMPRISING NICOTINIC ACID OR DERIVATIVE THEREOF AND FATTY ACID OR DERIVATIVE THEREOF

#679
US20250345300A1
Human necessities

DEVICES, SYSTEMS AND METHODS FOR MEDICAMENT DELIVERY

#680
US20250345301A1
Human necessities

COMPOSITIONS AND METHODS FOR IMPROVING EXERCISE PERFORMANCE OR PREVENTING OR RELIEVING FATIGUE

#681
US20250345302A1
Human necessities

Compositions and Methods For Reducing Immune Intolerance and Treating Autoimmune Disorders

#682
US20250345303A1
Human necessities

THERAPEUTIC COMPOSITIONS

#683
US20250345304A1
Human necessities

ASYMMETRIC SYNTHESIS AND USES OF COMPOUNDS IN DISEASE TREATMENTS

#684
US20250345305A1
Human necessities

Extended Duration Local Anesthetic Formulation

#685
US20250345306A1
Human necessities

ORAL LIQUID FORMULATION OF METHOCARBAMOL

#686
US20250345307A1
Human necessities

SYNTHETIC ROCAGLATES WITH BROAD-SPECTRUM ANTIVIRAL ACTIVITIES AND USES THEREOF

#687
US20250345308A1
Human necessities

COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING CONDITIONS

#688
US20250345309A1
Human necessities

IMMUNE HEALTH IMPROVERS

#689
US20250345310A1
Human necessities

MODULATORS OF TNF-ALPHA ACTIVITY

#690
US20250345311A1
Human necessities

CONJUGATE OF POLYPEPTIDE AND SMALL MOLECULE TARGETING KRAS AND ANTI-CANCER APPLICATION THEREOF

#691
US20250345312A1
Human necessities

FORMULATION AND METHOD FOR TREATMENT OF ALZHEIMER'S DISEASE, STROKE AND DIABETIC RETINOPATHY

#692
US20250345313A1
Human necessities

DRUG RESISTANT IMMUNOTHERAPY FOR TREATMENT OF A CANCER

#693
US20250345314A1
Human necessities

STEM CELL CONJUGATED WITH RAPAMYCIN-CONTAINING DRUG CARRIER AND USES THEREOF

#694
US20250345315A1
Human necessities

Dispenseable formulation for active pharmaceutical ingredients

#695
US20250345316A1
Human necessities

METHODS OF INCREASING LYMPHOCYTE TRAFFICKING TO THE COLON BY STIMULATING RETINOIC ACID RECEPTORS AND ARYL HYDROCARBON RECEPTORS

#696
US20250345317A1
Human necessities

New pharmaceutical compounds, methods and uses thereof

#697
US20250345318A1
Human necessities

COMPOUND AND USE THEREOF IN PREVENTING OR TREATING RADIATION DAMAGE

#698
US20250345319A1
Human necessities

Anticancer Compositions

#699
US20250345320A1
Human necessities

METHODS OF TREATMENT OF TRIGEMINAL NEURALGIA

#700
US20250345321A1
Human necessities

CATEQUENTINIB (ANLOTINIB) IN SEQUENTIAL COMBINATION WITH IMMUNOTHERAPY FOR USE IN THE TREATMENT OF CANCER

#701
US20250345322A1
Human necessities

NOVEL COMBINATION THERAPY OF CRENOLANIB AND APOPTOSIS PATHWAY AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS

#702
US20250345323A1
Human necessities

LYOPHILIZED ORALLY DISINTEGRATING TABLET FORMULATIONS OF d-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONS

#703
US20250345324A1
Human necessities

COMBINATION FORMULATIONS OF NALOXONE AND ATIPAMEZOLE

#704
US20250345325A1
Human necessities

BIOMARKERS FOR THE DIAGNOSIS AND TREATMENT OF FIBROTIC LUNG DISEASE

#705
US20250345326A1
Human necessities

METHODS FOR TREATING CHOLESTATIC PRURITUS

#706
US20250345327A1
Human necessities

PHARMACEUTICAL COMPOSITIONS OF PROTAC COMPOUNDS AND USES THEREOF

#707
US20250345328A1
Human necessities

METHODS OF TREATING A RAS RELATED DISEASE OR DISORDER

#708
US20250345329A1
Human necessities

HETEROARYL DERIVATIVE COMPOUND AND USES THEREOF

#709
US20250345330A1
Human necessities

COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL

#710
US20250345331A1
Human necessities

COUMARIN DERIVATIVE FOR THERAPY OR PROPHYLAXIS OF A CELL PROLIFERATIVE DISORDER

#711
US20250345332A1
Human necessities

APROCITENTAN FOR THE TREATMENT OF HYPERTENSION

#712
US20250345333A1
Human necessities

THERAPIES WITH PPAR AGONISTS AND FGFR4 INHIBITORS

#713
US20250345334A1
Human necessities

METHODS OF TREATING PROSTATE CANCER

#714
US20250345335A1
Human necessities

METHODS OF TREATING AND PREVENTING GRAFT VERSUS HOST DISEASE

#715
US20250345336A1
Human necessities

ALLOPURINOL ORAL SUSPENSION

#716
US20250345337A1
Human necessities

TOPICAL FORMULATION FOR A JAK INHIBITOR

#717
US20250345338A1
Human necessities

RUXOLITINIB FORMULATION FOR REDUCTION OF ITCH IN ATOPIC DERMATITIS

#718
US20250345339A1
Human necessities

DOSES AND REGIMENS OF HER2 INHIBITORS

#719
US20250345340A1
Human necessities

METHODS FOR THE PREVENTION AND TREATEMENT OF POST-OPERATIVE ABDOMINAL ADHESIONS

#720
US20250345341A1
Human necessities

4-Pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicament

#721
US20250345342A1
Human necessities

METHODS FOR THE TREATMENT OF CANCER USING 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL}PHENYL)-3-[4-(4,6-DIMORPHOLIN-4-YL-1,3,5-TRIAZIN-2-YL)PHENYL]UREA

#722
US20250345343A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF SOLID CANCER COMPRISING EPIDITHIODIOXOPIPERAZINE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

#723
US20250345344A1
Human necessities

NOVEL NRF2 ACTIVATOR AND USE THEREOF

#724
US20250345345A1
Human necessities

METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS

#725
US20250345346A1
Human necessities

METHODS OF TREATING ISCHEMIC STROKE AT RISK FOR CEREBRAL OR CEREBELLAR EDEMA

#726
US20250345347A1
Human necessities

METHODS OF TREATING ISCHEMIC STROKE AT RISK FOR CEREBRAL OR CEREBELLAR EDEMA

#727
US20250345348A1
Human necessities

AMPK ACTIVATOR (CBDA) AND SGLT2 INHIBITOR FOR METABOLIC HEALTH

#728
US20250345349A1
Human necessities

CANNABINOIDS IN THE TREATMENT OF EPILEPSY

#729
US20250345350A1
Human necessities

TREATING PAIN ASSOCIATED WITH CENTRAL SENSITIZATION

#730
US20250345351A1
Human necessities

OLIGOSACCHARIDE COMPOSITIONS AND METHODS OF USE

#731
US20250345352A1
Human necessities

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#732
US20250345353A1
Human necessities

COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS

#733
US20250345354A1
Human necessities

COMBINATION OF DNA-ENCODED BISPECIFIC T-CELL ENGAGERS TARGETING CANCER ANTIGENS AND METHODS OF USE IN CANCER THERAPEUTICS

#734
US20250345355A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING WOUNDS UTILIZING CHITOSAN COMPOUNDS

#735
US20250345356A1
Human necessities

TIRAPAZAMINE COMPOSITIONS AND METHODS

#736
US20250345357A1
Human necessities

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

#737
US20250345358A1
Human necessities

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

#738
US20250345359A1
Human necessities

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

#739
US20250345360A1
Human necessities

COMPOSITIONS OF OXYHYDROGEN AND THE THEREAPEUTIC USE THEREOF FOR OCULAR CONDITIONS

#740
US20250345361A1
Human necessities

COMPOSITIONS AND METHODS TO IMPROVE CALF GROWTH AND REDUCE INCIDENCE OF SCOURS

#741
US20250345362A1
Human necessities

MULTI-IONIC COMPLEX FOR THE PREVENTION OR TREATMENT OF INFLAMMATION

#742
US20250345363A1
Human necessities

ANTIMICROBIAL AND ANTIBIOFILM COMPOSITIONS AND USES THEREOF

#743
US20250345364A1
Human necessities

CISH GENE EDITING OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY

#744
US20250345365A1
Human necessities

TREATMENT OF NEURONAL DISEASES

#745
US20250345366A1
Human necessities

MYOBLAST CHIMERIC CELLS (MCCs)

#746
US20250345367A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING OVARIAN FAILURE COMPRISING UMBILICAL CORD-DERIVED ADHERENT STEM CELLS

#747
US20250345368A1
Human necessities

Herring Sperm DNA, as a means of causing Cancer Cells to go into a dormant state, or to stall or inhibit the growth or metastasis of the Cancer Cells

#748
US20250345369A1
Human necessities

ENGINEERED IMMUNOSTIMULATORY BACTERIAL STRAINS AND USES THEREOF

#749
US20250345370A1
Human necessities

MICROBIAL LIBERATION OF N-METHYLSEROTONIN FROM ORANGE FIBER

#750
US20250345371A1
Human necessities

BACILLUS VELEZENSIS COMPOSITIONS AND METHODS OF USE THEREOF

#751
US20250345372A1
Human necessities

USE OF DOPAMINE PRODUCING PRODUCTS TO INCREASE VACCINE EFFICACY

#752
US20250345373A1
Human necessities

TREATMENT OF INFLAMMATION IN ELDERLY

#753
US20250345374A1
Human necessities

METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE USING BACILLUS AMYLOLIQUEFACIENS

#754
US20250345375A1
Human necessities

LACTOBACILLUS CRISPATUS COMPOSITION FOR USE IN PREGNANT SUBJECTS

#755
US20250345376A1
Human necessities

METHOD FOR ALLEVIATING PARTICULATE MATTER-INDUCED LUNG INJURY CAUSED BY PARTICULATE MATTER WITH DIAMETER OF NOT GREATER THAN 2.5 µm (PM2.5) USING ISOLATED STRAIN OF LACTOBACILLUS ACIDOPHILUS TW01

#756
US20250345377A1
Human necessities

BIOMARKERS FOR CANCER THERAPEUTICS

#757
US20250345378A1
Human necessities

PHAGE COMPOSITIONS FOR ESCHERICHIA COMPRISING CRISPR-CAS SYSTEMS AND METHODS OF USE THEREOF

#758
US20250345379A1
Human necessities

METHODS AND COMPOSITIONS FOR REDUCING BODY WEIGHT IN MAMMALS

#759
US20250345380A1
Human necessities

HERBAL EXTRACT COMPOSITION FOR THE TREATMENT OF OSTEOARTHRITIS AND CARTILAGE REGENERATION

#760
US20250345381A1
Human necessities

TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING CARDIOVASCULAR AND KIDNEY DISEASES AND METHOD FOR PREPARING SAME

#761
US20250345382A1
Human necessities

METHOD FOR PREVENTING OR TREATING PROSTATIC HYPERPLASIA

#762
US20250345383A1
Human necessities

INTRANASAL ADMINISTRATION OF POLYSULFIDE

#763
US20250345384A1
Human necessities

STABLE CYCLODEXTRIN FREE CARFILZOMIB FORMULATION

#764
US20250345385A1
Human necessities

MIXTURES AND FORMULATIONS COMPRISING AN ALKYL AMMONIUM EDTA SALT

#765
US20250345386A1
Human necessities

MICAFUNGIN COMPOSITIONS

#766
US20250345387A1
Human necessities

CORONAVIRUS THERAPEUTICS AND TREATMENT METHODS

#767
US20250345388A1
Human necessities

BINDING MOLECULES TO TUMOR ASSOCIATED MACROPHAGES AND METHODS OF USE

#768
US20250345389A1
Human necessities

COMBINATION THERAPIES

#769
US20250345390A1
Human necessities

COMBINATION THERAPIES

#770
US20250345391A1
Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENT OF SEPSIS

#771
US20250345392A1
Human necessities

ANNEXIN A1 LIQUID PHARMACEUTICAL COMPOSITION

#772
US20250345393A1
Human necessities

ISOFORM NELL-1 PEPTIDE

#773
US20250345394A1
Human necessities

HAIR-GROWING OR HAIR-FOSTERING AGENT BASED ON KERATIN FINE PARTICLES

#774
US20250345395A1
Human necessities

Dosing Regimens of SIRP Alpha Fusion Proteins for Treatment of Cancer

#775
US20250345396A1
Human necessities

TREATMENT OF INFLAMMATORY CONDITIONS BY DELIVERY OF INTERLEUKIN-1 RECEPTOR ANTAGONIST FUSION PROTEIN

#776
US20250345397A1
Human necessities

IL-15 MUTANT-Fc/IL-15R ALPHA SUBUNIT-Fc HETERODIMER AND USE THEREOF

#777
US20250345398A1
Human necessities

AGENTS AND METHODS FOR TREATING DISEASE

#778
US20250345399A1
Human necessities

THROMBOMODULIN PROTEIN AND MIRNA FOR PREVENTING OR TREATING OSTEOATHRITIS

#779
US20250345400A1
Human necessities

METHODS FOR TREATMENT OF COGNITIVE IMPAIRMENT IN CIRRHOSIS PATIENTS

#780
US20250345401A1
Human necessities

TOPICAL THERAPEUTIC FORMULATIONS

#781
US20250345402A1
Human necessities

GENE THERAPY FOR TREATING MUCOPOLYSACCHARIDOSIS TYPE II

#782
US20250345403A1
Human necessities

HYALURONIDASE HYAL1 VARIANT EXHIBITING ACTIVITY IN NEUTRAL PH

#783
US20250345404A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE

#784
US20250345405A1
Human necessities

ENZYME COMPOSITIONS WITH REDUCED VIRAL AND MICROBIAL CONTAMINATION

#785
US20250345406A1
Human necessities

CHIMERIC PROTEINS IN AUTOIMMUNITY

#786
US20250345407A1
Human necessities

NUCLEIC ACID BASED VACCINE ENCODING AN ESCHERICHIA COLI FIMH ANTIGENIC POLYPEPTIDE

#787
US20250345408A1
Human necessities

BCG VACCINATIONS FOR PREVENTION OF COVID-19 AND OTHER INFECTIOUS DISEASES

#788
US20250345409A1
Human necessities

COMPOSITIONS AND METHODS FOR THERAPEUTIC OR VACCINE DELIVERY

#789
US20250345410A1
Human necessities

VACCINATION IN NEWBORNS AND INFANTS

#790
US20250345411A1
Human necessities

VACCINATION IN NEWBORNS AND INFANTS

#791
US20250345412A1
Human necessities

Coronavirus Vaccine

#792
US20250345413A1
Human necessities

SARS-COV-2 SUBUNIT VACCINE

#793
US20250345414A1
Human necessities

ADENOVIRAL VECTOR-BASED VACCINE FOR EMERGING VIRUSES

#794
US20250345415A1
Human necessities

SARS-CoV-2 Vaccine Constructs

#795
US20250345416A1
Human necessities

PHARMACEUTICAL COMPOSITIONS FOR DELIVERY OF HERPES SIMPLEX VIRUS ANTIGENS AND RELATED METHODS

#796
US20250345417A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATMENT OF MELANOMA

#797
US20250345418A1
Human necessities

METHODS OF TREATING AL AMYLOIDOSIS

#798
US20250345419A1
Human necessities

TREATING CHEMORESISTANT CANCERS WITH NOTCH3 INHIBITORS

#799
US20250345420A1
Human necessities

CANCER IMMUNOTHERAPIES TO PROMOTE HYPERACUTE REJECTION

#800
US20250345421A1
Human necessities

REDUCING VISCOSITY OF PHARMACEUTICAL FORMULATIONS

#801
US20250345422A1
Human necessities

PHARMACEUTICAL COMPOSITIONS OF A PD-1 ANTIBODY AND USE OF THE SAME

#802
US20250345423A1
Human necessities

BINDING DOMAIN MOLECULES ON CELL SURFACES

#803
US20250345424A1
Human necessities

TREATMENT OF AUTOIMMUNE DISEASES WITH ENGINEERED IMMUNE CELLS

#804
US20250345425A1
Human necessities

CELLS ENGINEERED WITH AN HLA-E AND HLA-G TRANSGENE

#805
US20250345426A1
Human necessities

METHODS FOR MAKING AND USING THERAPEUTIC CELLS

#806
US20250345427A1
Human necessities

Method

#807
US20250345428A1
Human necessities

Microfluidic System for Transplantation of Mitochondria in Immune Effector Cells

#808
US20250345429A1
Human necessities

COMPOSITIONS AND METHODS COMPRISING CHIMERIC ADAPTOR POLYPEPTIDES

#809
US20250345430A1
Human necessities

PLURIPOTENT STEM CELL-DERIVED IMMUNE CELL INDUCING CHEMOTAXIS FOR HETEROGENEOUS IMMUNE CELLS

#810
US20250345431A1
Human necessities

GENETICALLY ENGINEERED T CELLS EXPRESSING A CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) AND USES THEREOF FOR ALLOGENEIC CELL THERAPY

#811
US20250345432A1
Human necessities

METHOD FOR PREDICTING RESPONSE TO A T CELL THERAPY

#812
US20250345433A1
Human necessities

Drug For Treating Disorders Of An Organ Or Tissue Function And Diseases Accompanied By Such Disorders, And The Method For Obtaining It

#813
US20250345434A1
Human necessities

BORONATED HYDROGELS AND METHODS OF MAKING AND USING THE SAME

#814
US20250345435A1
Human necessities

ANHYDROUS SODIUM THIOSULFATE AND FORMULATIONS THEREOF

#815
US20250345436A1
Human necessities

USE OF VITAMIN E TPGS AS A TASTE MASKING AGENT FOR BITTER DRUGS

#816
US20250345437A1
Human necessities

GLUTEN-FREE MEDICATION AID COMPOSITION FOR COMPANION ANIMALS, AND METHOD FOR MANUFACTURING THE SAME

#817
US20250345438A1
Human necessities

PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY

#818
US20250345439A1
Human necessities

CHONDROITIN SULFATE BIOGENIC POLYAMINE COMPLEX, PREPARATION METHOD THEREOF AND USE THEREOF

#819
US20250345440A1
Human necessities

METAL-ORGANIC FRAMEWORK MATERIALS AND USES OF THE METAL-ORGANIC FRAMEWORK MATERIALS

#820
US20250345441A1
Human necessities

ANTICANCER DRUGS AND METHODS OF MAKING AND USING SAME

#821
US20250345442A1
Human necessities

PROTEIN AND PEPTIDE DELIVERY SYSTEMS AND METHODS FOR MAKING AND USING THEM

#822
US20250345443A1
Human necessities

PHARMACEUTICAL COMPOUND AND USE THEREOF

#823
US20250345444A1
Human necessities

CLEAVABLE FRAGMENT DIRECTED BY AFFINITY FRAGMENT, DESIGN AND SYNTHESIS THEREOF, AND USE THEREOF IN PREPARATION OF SITE-DIRECTED DRUG CONJUGATE

#824
US20250345445A1
Human necessities

ANTIBODY-DRUG CONJUGATE AND USE THEREOF

#825
US20250345446A1
Human necessities

BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES

#826
US20250345447A1
Human necessities

PHARMACEUTICAL COMPOSITION OF RECOMBINANT ANTI-HUMAN CLDN18.2 MONOCLONAL ANTIBODY-MMAE CONJUGATE

#827
US20250345448A1
Human necessities

POLYPEPTIDES ANTAGONIZING WNT SIGNALING IN TUMOR CELLS

#828
US20250345449A1
Human necessities

ANTI-CD123 IMMUNOCONJUGATES FOR THE TREATMENT OF BLASTIC PLASMACYTOID CELL NEOPLASM

#829
US20250345450A1
Human necessities

ANTIBODY-MEDIATED CONDITIONING WITH IMMUNOSUPPRESSION TO ENABLE ALLOGENEIC TRANSPLANTATION

#830
US20250345451A1
Human necessities

ANTI-PD-L1 SINGLE-DOMAIN ANTIBODY AND DERIVATIVES AND USE THEREOF

#831
US20250345452A1
Human necessities

METHODS FOR THE TREATMENT OF PATIENTS WITH FOLATE RECEPTOR ALPHA-EXPRESSING CANCERS

#832
US20250345453A1
Human necessities

CHEMOTHERAPEUTIC MICELLULAR NANOPARTICLES

#833
US20250345454A1
Human necessities

CHEMOTHERAPEUTIC PACLITAXEL BASED MICELLULAR NANOPARTICLES

#834
US20250345455A1
Human necessities

BISPECIFIC NANOPARTICLE BIOCONJUGATES

#835
US20250345456A1
Human necessities

Targeted Poly(beta-amino ester)s

#836
US20250345457A1
Human necessities

FUNCTIONALIZED DIBLOCK COPOLYMER AND ITS PREPARATION METHOD AND APPLICATION

#837
US20250345458A1
Human necessities

COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS

#838
US20250345459A1
Human necessities

COMPOUND OR SALT THEREOF, LIPID COMPOSITION, PHARMACEUTICAL COMPOSITION, AND DELIVERY CARRIER

#839
US20250345460A1
Human necessities

COMPOSITION AND METHOD FOR TREATMENT OF LCA10 USING RNA-GUIDED NUCLEASE

#840
US20250345461A1
Human necessities

METHOD FOR REPAIRING HAIR CYCLE-RELATED GENES AND METHOD FOR TREATING HAIR CYCLE-RELATED DISEASES USING MIR-520D-5P

#841
US20250345462A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING LIVER DISEASE

#842
US20250345463A1
Human necessities

GENE THERAPY FOR MONOGENIC DIABETES

#843
US20250345464A1
Human necessities

GENE THERAPY FOR TREATING NEURODEGENERATIVE DISEASES

#844
US20250345465A1
Human necessities

DUAL T1/T2 MRI CONTRAST AGENTS FOR PHOTOTHERMAL THERAPY

#845
US20250345466A1
Human necessities

DOTA-HAPTEN COMPOSITIONS FOR ANTI-DOTA/ANTI-TUMOR ANTIGEN BISPECIFIC ANTIBODY PRETARGETED RADIOIMMUNOTHERAPY

#846
US20250345467A1
Human necessities

DENDRIMER FOR THERAPY AND IMAGING

#847
US20250345468A1
Human necessities

COMBINATION TREATMENT OF SMALL-CELL LUNG CANCER

#848
US20250345469A1
Human necessities

COMPOSITION COMPRISING A RAPALOG AND A RADIOLABELLED GASTRIN ANALOGUE, IN PARTICULAR FOR USE IN THE TREATMENT AND/OR DIAGNOSIS OF CCKB RECEPTOR POSITIVE CANCER OR TUMORS

#849
US20250345470A1
Human necessities

RADIOPHARMACEUTICAL COMPOSITIONS FOR LOW TOXICITY ACTINIUM IN TARGETED RADIONUCLIDE THERAPY

#850
US20250345471A1
Human necessities

SYSTEMS AND METHODS FOR TREATING BIOLOGICAL FLUIDS

#851
US20250345472A1
Human necessities

Ultraviolet Light Attachment for Coin Counter

#852
US20250345473A1
Human necessities

DIRECTIONAL ULTRAVIOLET PROJECTION DEVICES AND RELATED METHODS OF USE

#853
US20250345474A1
Human necessities

METHOD FOR THE CHEMICAL DISINFECTION OF A REVERSE OSMOSIS SYSTEM AND REVERSE OSMOSIS SYSTEM

#854
US20250345475A1
Human necessities

APPARATUS AND METHOD FOR TREATING AND IN PARTICULAR STERILIZING PLASTIC PREFORMS OR CONTAINERS

#855
US20250345476A1
Human necessities

DEVICE FOR DISCHARGING A DISINFECTING SOLUTION

#856
US20250345477A1
Human necessities

ULTRAVIOLET LIGHT DISINFECTION SYSTEM AND METHOD

#857
US20250345478A1
Human necessities

PHOTOCROSSLINKABLE SYNTHETIC POLYMERS

#858
US20250345479A1
Human necessities

PH-SENSITIVE WOUND DRESSING

#859
US20250345480A1
Human necessities

Bioink Compositions and Methods for 3D Printing Of Vascularized Tissue Constructs

#860
US20250345481A1
Human necessities

NANOCOMPOSITE HYDROGELS AND RELATED METHODS AND APPLICATIONS

#861
US20250345482A1
Human necessities

3D PRINTED GALLIUM SCAFFOLD

#862
US20250345483A1
Human necessities

WIDE RANGE SYNTHETIC PEPTIDE NUCLEIC ACIDS AND THEIR APPLICATIONS

#863
US20250345484A1
Human necessities

METHODS OF ISOLATING AND USING DESCEMET'S MEMBRANE AND COMPOSITIONS INCLUDING ISOLATED DESCEMET'S MEMBRANE

#864
US20250345485A1
Human necessities

FIBROUS TISSUE DERIVED MATERIAL AND COMPOSITIONS COMPRISING SAME AND METHODS FOR MAKING AND USING SAME

#865
US20250345486A1
Human necessities

AUTOMATED SYSTEM AND METHODS FOR TISSUE DEMINERALIZATION

#866
US20250345487A1
Human necessities

COMPOSITE HYDROGEL AND USES THEREOF

#867
US20250345488A1
Human necessities

CROSSLINKED HYDROGELS WITH ENHANCED RADIOPACITY FOR MEDICAL APPLICATIONS

#868
US20250345489A1
Human necessities

POROUS COMPOSITE MATERIAL, MANUFACTURING METHOD THEREOF AND BONE SUBSTITUTE MATERIAL USING THE SAME

#869
US20250345490A1
Human necessities

BIOLOGIC MATRIX FOR A WOUND SITE AND RELATED METHODS

#870
US20250345491A1
Human necessities

IMPROVED NERVE REGENERATION SCAFFOLD FOR ACCELERATED REGROWTH

#871
US20250345492A1
Human necessities

AN ANTIBACTERIAL POLYPEPTIDE COMPOUND, A MEDICAL DEVICE, HYDROGEL AND USE THEREOF

#872
US20250345493A1
Human necessities

ANTIMICROBIAL COMPOSITIONS: METHODS OF MAKING AND USING THE SAME

#873
US20250345494A1
Human necessities

APHERESIS REGISTRATION SYSTEM

#874
US20250345495A1
Human necessities

RED BLOOD CELL ADDITIVE SOLUTION MANAGEMENT AND STORAGE OF RED BLOOD CELL PRODUCTS

#875
US20250345496A1
Human necessities

A SYSTEM FOR DETERMINING THE MAGNITUDE OF THE ULTRAFILTRATION VOLUME EXPECTED IN A PERITONEAL DIALYSIS TREATMENT

#876
US20250345497A1
Human necessities

SYSTEM AND METHOD FOR CONNECTING A CONCENTRATE CONTAINER WITH A BLOOD TREATMENT DEVICE

#877
US20250345498A1
Human necessities

Water Treatment Systems, Devices, and Methods for Fluid Preparation

#878
US20250345499A1
Human necessities

PATIENT BODY TEMPERATURE CONTROL DURING GAS EXCHANGE TREATMENT

#879
US20250345500A1
Human necessities

DEVICES AND METHODS FOR EXTRACORPOREAL CONDITIONING OF BLOOD

#880
US20250345501A1
Human necessities

AUTOMATED PERITONEAL DIALYSIS SYSTEM HAVING A DRAIN PURGE

#881
US20250345502A1
Human necessities

Medicament Preparation Devices, Methods, and Systems

#882
US20250345503A1
Human necessities

CONTACTLESS ACTUATION FOR VALVE IMPLANT

#883
US20250345504A1
Human necessities

Needle Dislodgement Detection Systems and Methods

#884
US20250345505A1
Human necessities

SYSTEM AND METHOD FOR COLLECTING PLASMA

#885
US20250345506A1
Human necessities

DRAINAGE BOTTLE MONITORING SYSTEM AND METHOD THEREOF

#886
US20250345507A2
Human necessities

MEDICAL TREATMENT SYSTEM AND METHODS USING A PLURALITY OF FLUID LINES

#887
US20250345508A1
Human necessities

ASPIRATION FLOW CONTROL VALVE

#888
US20250345509A1
Human necessities

SYSTEMS AND METHODS FOR MECHANICAL DISPLACEMENT OF AN ESOPHAGUS

#889
US20250345510A1
Human necessities

PACKAGED NEEDLE ASSEMBLY

#890
US20250345511A1
Human necessities

INFUSION LINE SYSTEMS

#891
US20250345512A1
Human necessities

COMBINATION SODIUM-GLUCOSE COTRANSPORTER INHIBITOR (SGLTI) INSULIN THERAPY FOR GLYCEMIC CONTROL IN TYPE 1 DIABETES

#892
US20250345513A1
Human necessities

FLUID MANAGEMENT SYSTEM WITH INTEGRAL PRESSURE REGULATION MECHANISM

#893
US20250345514A1
Human necessities

MULTIPLE TELESCOPING SCREW-DRIVEN PUMP MECHANISM WITH ANTI-ROTATION OF INNERMOST SCREW KEYED TO RESERVOIR PLUNGER IN FLUID DELIVERY DEVICE

#894
US20250345515A1
Human necessities

VASCULAR ACCESS DEVICE AND METHODS

#895
US20250345516A1
Human necessities

AMBULATORY INFUSION PUMPS AND ASSEMBLIES FOR USE WITH SAME

#896
US20250345517A1
Human necessities

AMBULATORY INFUSION PUMPS AND ASSEMBLIES FOR USE WITH SAME

#897
US20250345518A1
Human necessities

USE OF CATH LAB IMAGES FOR PREDICTION AND CONTROL OF CONTRAST USAGE

#898
US20250345519A1
Human necessities

Reusable Digital Module for Autoinjector

#899
US20250345520A1
Human necessities

AN ENERGY HARVESTING SUBASSEMBLY OF A MEDICAMENT DELIVERY DEVICE

#900
US20250345521A1
Human necessities

Injector